Published in Nat Struct Mol Biol on March 14, 2010
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell (2011) 2.83
The extracellular architecture of adherens junctions revealed by crystal structures of type I cadherins. Structure (2011) 2.19
Spatial organization of transmembrane receptor signalling. EMBO J (2010) 2.03
Architecture of Eph receptor clusters. Proc Natl Acad Sci U S A (2010) 1.82
Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets (2011) 1.65
Cooperativity between trans and cis interactions in cadherin-mediated junction formation. Proc Natl Acad Sci U S A (2010) 1.46
Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model". Bioessays (2015) 1.43
Eph receptor signaling and ephrins. Cold Spring Harb Perspect Biol (2013) 1.33
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. J Cell Biol (2011) 1.08
EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J Cell Biol (2013) 1.06
Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat Rev Mol Cell Biol (2016) 1.05
Effects of cancer-associated EPHA3 mutations on lung cancer. J Natl Cancer Inst (2012) 1.02
Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry (2012) 1.01
Structurally encoded intraclass differences in EphA clusters drive distinct cell responses. Nat Struct Mol Biol (2013) 1.00
Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. Adv Cancer Res (2012) 0.98
The composition of EphB2 clusters determines the strength in the cellular repulsion response. J Cell Biol (2014) 0.97
Theory and simulations of adhesion receptor dimerization on membrane surfaces. Biophys J (2013) 0.97
Collagen recognition and transmembrane signalling by discoidin domain receptors. Biochim Biophys Acta (2012) 0.96
Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5. Proc Natl Acad Sci U S A (2013) 0.95
Automation of large scale transient protein expression in mammalian cells. J Struct Biol (2011) 0.95
Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands. PLoS One (2013) 0.94
Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor. Biochem J (2012) 0.93
Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation. Biochim Biophys Acta (2013) 0.93
Protein dynamics at Eph receptor-ligand interfaces as revealed by crystallography, NMR and MD simulations. BMC Biophys (2012) 0.93
FLRT structure: balancing repulsion and cell adhesion in cortical and vascular development. Neuron (2014) 0.92
Structure and binding mechanism of vascular endothelial cadherin: a divergent classical cadherin. J Mol Biol (2011) 0.91
Cells under siege: viral glycoprotein interactions at the cell surface. J Struct Biol (2011) 0.91
Correlative in-resin super-resolution and electron microscopy using standard fluorescent proteins. Sci Rep (2015) 0.90
Expression of recombinant glycoproteins in mammalian cells: towards an integrative approach to structural biology. Curr Opin Struct Biol (2013) 0.90
Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode. Nat Commun (2015) 0.89
EphrinA6 on chick retinal axons is a key component for p75(NTR)-dependent axon repulsion and TrkB-dependent axon branching. Mol Cell Neurosci (2011) 0.89
Nanoscale obstacle arrays frustrate transport of EphA2-Ephrin-A1 clusters in cancer cell lines. Nano Lett (2013) 0.88
Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection. PLoS Pathog (2015) 0.88
The spatial structure of cell signaling systems. Phys Biol (2013) 0.86
Structural basis of latrophilin-FLRT interaction. Structure (2015) 0.86
EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling. J Biol Chem (2015) 0.84
Targeting the Eph System with Peptides and Peptide Conjugates. Curr Drug Targets (2015) 0.84
Dimerization of the EphA1 receptor tyrosine kinase transmembrane domain: Insights into the mechanism of receptor activation. Biochemistry (2014) 0.83
Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor. ACS Med Chem Lett (2013) 0.83
EphB/ephrinB signaling in cell adhesion and migration. Mol Cells (2014) 0.82
Eph/ephrin signaling in epidermal differentiation and disease. Semin Cell Dev Biol (2011) 0.82
The SAM domain inhibits EphA2 interactions in the plasma membrane. Biochim Biophys Acta (2016) 0.80
Unliganded EphA3 dimerization promoted by the SAM domain. Biochem J (2015) 0.80
Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1. Biophys J (2014) 0.80
Normal activation of discoidin domain receptor 1 mutants with disulfide cross-links, insertions, or deletions in the extracellular juxtamembrane region: mechanistic implications. J Biol Chem (2014) 0.80
Tie2 and Eph receptor tyrosine kinase activation and signaling. Cold Spring Harb Perspect Biol (2014) 0.79
Completing the structural family portrait of the human EphB tyrosine kinase domains. Protein Sci (2014) 0.79
Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations. PLoS One (2013) 0.79
Size-based chromatography of signaling clusters in a living cell membrane. Nano Lett (2014) 0.79
Eph-ephrin signaling in nervous system development. F1000Res (2016) 0.79
Homotypic receptor-receptor interactions regulating Eph signaling. Cell Adh Migr (2014) 0.78
Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase. J Biol Chem (2014) 0.78
Super-complexes of adhesion GPCRs and neural guidance receptors. Nat Commun (2016) 0.77
A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers. Biochim Biophys Acta (2016) 0.77
Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions. Structure (2015) 0.76
Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5. PLoS One (2015) 0.76
Dimerization of Tie2 mediated by its membrane-proximal FNIII domains. Proc Natl Acad Sci U S A (2017) 0.76
Eph and Ephrin function in dispersal and epithelial insertion of pigmented immunocytes in sea urchin embryos. Elife (2016) 0.75
A role of the SAM domain in EphA2 receptor activation. Sci Rep (2017) 0.75
Tiam-Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion. J Cell Biol (2016) 0.75
The Neural Cell Adhesion Molecule NCAM Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce RhoA/ROCK-mediated Growth Cone Collapse. J Biol Chem (2016) 0.75
Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation. Mol Biol Cell (2016) 0.75
Engineering of monobody conjugates for human EphA2-specific optical imaging. PLoS One (2017) 0.75
Dendritic Eph organizes dendrodendritic segregation in discrete olfactory map formation in Drosophila. Genes Dev (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Improved prediction of signal peptides: SignalP 3.0. J Mol Biol (2004) 48.40
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol (2002) 22.05
The integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr (2005) 19.21
Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol (2005) 7.14
Eph-ephrin bidirectional signaling in physiology and disease. Cell (2008) 7.12
Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A (2002) 5.91
A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr (2006) 5.17
Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J (2002) 4.83
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci (2004) 4.22
Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron (1996) 4.12
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr (2005) 3.75
Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science (1994) 3.53
Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science (1991) 3.24
EphA2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res (2001) 3.24
Lysine methylation as a routine rescue strategy for protein crystallization. Structure (2006) 3.14
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol (2000) 3.09
Crystal structure of an Eph receptor-ephrin complex. Nature (2002) 2.80
Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40
Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell (1997) 2.31
Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol (2007) 2.24
The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting. Mol Cancer Res (2008) 2.21
E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ (1999) 2.01
cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol Cell Biol (1990) 1.98
Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci (2006) 1.86
Oligomeric structure of the human EphB2 receptor SAM domain. Science (1999) 1.83
Eph signaling: a structural view. Trends Neurosci (2003) 1.74
EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol (2002) 1.72
Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci U S A (2008) 1.58
EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer (2007) 1.57
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis (2003) 1.53
Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J Cell Biol (2004) 1.52
Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem (2003) 1.48
Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J Biol Chem (2007) 1.44
Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron (2005) 1.44
Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep (2009) 1.42
Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity. J Biol Chem (2006) 1.40
Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem (2008) 1.33
EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol Biol Cell (2009) 1.30
Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. Structure (2009) 1.29
Expression of Eph receptors and ephrins is differentially regulated by E-cadherin. J Cell Sci (2000) 1.22
Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J Biol Chem (2008) 1.21
Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases. Protein Sci (1996) 1.04
Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. FEBS Lett (2005) 0.99
"Eph receptor signalling; dimerisation just isn't enough". Growth Factors (2005) 0.98
Crystal structure of the human ephrin-A5 ectodomain. Protein Sci (2007) 0.88
A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr (2006) 5.17
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature (2002) 3.78
A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr D Biol Crystallogr (2005) 3.75
The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol (2005) 3.53
A structural basis for immunodominant human T cell receptor recognition. Nat Immunol (2003) 3.15
Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol (2002) 2.70
Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol (2008) 2.58
Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med (2007) 2.37
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol (2005) 2.33
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A (2003) 2.33
A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol (2002) 2.31
The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity (2008) 2.31
Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med (2005) 2.22
Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med (2008) 2.19
Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet (2003) 2.16
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol (2006) 2.11
T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med (2004) 1.99
Structure of the integrin binding fragment from fibrillin-1 gives new insights into microfibril organization. Structure (2004) 1.97
In situ macromolecular crystallography using microbeams. Acta Crystallogr D Biol Crystallogr (2012) 1.94
Distinct binding modes of two epitopes in Gab2 that interact with the SH3C domain of Grb2. Structure (2009) 1.89
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol (2009) 1.83
Structural basis of substrate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol (2011) 1.81
Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell (2008) 1.68
The ligand-binding face of the semaphorins revealed by the high-resolution crystal structure of SEMA4D. Nat Struct Biol (2003) 1.68
The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol (2004) 1.64
Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism. Science (2007) 1.64
A dual binding mode for RhoGTPases in plexin signalling. PLoS Biol (2011) 1.63
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med (2004) 1.60
Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity (2007) 1.60
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol (2005) 1.60
Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science (2011) 1.59
Structural basis of semaphorin-plexin signalling. Nature (2010) 1.58
Crystal structure of the GluR2 amino-terminal domain provides insights into the architecture and assembly of ionotropic glutamate receptors. J Mol Biol (2009) 1.53
Structural and functional studies of LRP6 ectodomain reveal a platform for Wnt signaling. Dev Cell (2011) 1.50
T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity (2009) 1.50
How baculovirus polyhedra fit square pegs into round holes to robustly package viruses. EMBO J (2009) 1.46
The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci (2003) 1.46
Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell (2005) 1.45
Biology of CD1- and MR1-restricted T cells. Annu Rev Immunol (2014) 1.44
Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Curr Opin Cell Biol (2007) 1.41
Eukaryotic expression: developments for structural proteomics. Acta Crystallogr D Biol Crystallogr (2006) 1.41
Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76. EMBO J (2003) 1.38
PCNA directs type 2 RNase H activity on DNA replication and repair substrates. Nucleic Acids Res (2011) 1.35
Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol (2008) 1.32
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med (2006) 1.32
Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure (2003) 1.32
The sema domain. Curr Opin Struct Biol (2004) 1.31
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats. Nat Genet (2013) 1.30
Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A (2004) 1.29
Structural insights into hedgehog ligand sequestration by the human hedgehog-interacting protein HHIP. Nat Struct Mol Biol (2009) 1.29
Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. Structure (2009) 1.29
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. Cancer Cell (2013) 1.28
Protein tyrosine phosphatases: structure-function relationships. FEBS J (2008) 1.27
Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure (2002) 1.23
Rational development of high-affinity T-cell receptor-like antibodies. Proc Natl Acad Sci U S A (2009) 1.23
Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helix. J Biol Chem (2004) 1.21
Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol (2011) 1.21
Benefits of automated crystallization plate tracking, imaging, and analysis. Structure (2005) 1.19
Structure of a pestivirus envelope glycoprotein E2 clarifies its role in cell entry. Cell Rep (2012) 1.18
Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology (2006) 1.18
The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease. J Biol Chem (2010) 1.17
Crystal structure of a clavaminate synthase-Fe(II)-2-oxoglutarate-substrate-NO complex: evidence for metal centered rearrangements. FEBS Lett (2002) 1.17
Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J Immunol (2008) 1.17
Structures of an alanine racemase from Bacillus anthracis (BA0252) in the presence and absence of (R)-1-aminoethylphosphonic acid (L-Ala-P). Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 1.15
Structural and functional aspects of lipid binding by CD1 molecules. Annu Rev Cell Dev Biol (2008) 1.14
Structure and functional analysis of the IGF-II/IGF2R interaction. EMBO J (2007) 1.14
Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol (2010) 1.14
Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J Am Chem Soc (2012) 1.12
Unusual molecular architecture of the machupo virus attachment glycoprotein. J Virol (2009) 1.12
The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J Biol Chem (2007) 1.11
High-resolution structure of the catalytic region of MICAL (molecule interacting with CasL), a multidomain flavoenzyme-signaling molecule. Proc Natl Acad Sci U S A (2005) 1.11
Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection. J Immunol (2006) 1.09